Search research articles
Contact Us
Filters
Showing results (101-110 of 220) with videos related to
Page
of 22
Sort By:
Neuro-Degenerative Diseases
|
August 9, 2018
Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative
Samuel Iddi, Dan Li, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 10, 2020
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach
Michael C Donohue, Fabian Model, Paul Delmar, et al.
Blood
|
August 15, 2000
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
G J Roboz, S Dias, G Lam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 19, 2026
Precision medicine for Alzheimer's disease in Down syndrome
Sonal Sukreet, Elise K Kim, Melissa Petersen, et al.
Journal of Neurology
|
September 13, 2020
Neurologic complications of Down syndrome: a systematic review
Jonathan D Santoro, Dania Pagarkar, Duong T Chu, et al.
Blood
|
May 16, 1998
High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors
B M Frey, N R Hackett, J M Bergelson, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2019
Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Michael S Rafii, Michael C Donohue, Dawn C Matthews, et al.
Blood
|
July 1, 1994
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion
S Rafii, F Shapiro, J Rimarachin, et al.
Microvascular Research
|
November 1, 1996
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics
F J Candal, S Rafii, J T Parker, et al.
The Journal of Experimental Medicine
|
October 23, 1997
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
W Song, H L Kong, H Carpenter, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 220) with videos related to
Sort By:
Page
of 22
Neuro-Degenerative Diseases
|
August 9, 2018
Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative
Samuel Iddi, Dan Li, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 10, 2020
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach
Michael C Donohue, Fabian Model, Paul Delmar, et al.
Blood
|
August 15, 2000
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
G J Roboz, S Dias, G Lam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 19, 2026
Precision medicine for Alzheimer's disease in Down syndrome
Sonal Sukreet, Elise K Kim, Melissa Petersen, et al.
Journal of Neurology
|
September 13, 2020
Neurologic complications of Down syndrome: a systematic review
Jonathan D Santoro, Dania Pagarkar, Duong T Chu, et al.
Blood
|
May 16, 1998
High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors
B M Frey, N R Hackett, J M Bergelson, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2019
Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Michael S Rafii, Michael C Donohue, Dawn C Matthews, et al.
Blood
|
July 1, 1994
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion
S Rafii, F Shapiro, J Rimarachin, et al.
Microvascular Research
|
November 1, 1996
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics
F J Candal, S Rafii, J T Parker, et al.
The Journal of Experimental Medicine
|
October 23, 1997
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
W Song, H L Kong, H Carpenter, et al.
Page
of 22